Empirical Wealth Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Empirical Wealth Management's RVMD Position: Q3 2026 in Review
Empirical Wealth Management increased its Revolution Medicines (RVMD) stake by 12% in Q3 2026, buying an estimated $29.3K and bringing the position to 1,401 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #976.
Empirical Wealth Management first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Empirical Wealth Management held 1,401 shares of Revolution Medicines worth $288K as of Q3 2026.
- Empirical Wealth Management bought 148 Revolution Medicines shares in Q3 2026, an estimated $29.3K.
- Revolution Medicines made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #976 holding.
- Empirical Wealth Management first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
- 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.